glp-1 medicare New Bridge Program Medicare GLP-1 Bridge Program Expands

Despite their exploding popularity, the current GLP-1 injections (semaglutide though is also orally available) face accessibility issues due to cost and adverse effects and thus the next big move for the space, an easy to - pop pill could be lucrative, for which clinical trials are already well underway

Explore Fridays' weight loss program pricing model

Microdosing GLP-1 for Hashimoto's: explore the evidence, potential benefits, safety concerns, and NHS guidance on using GLP-1 receptor agonists for autoimmune thyroid disease and metabolic symptoms.

This alert explains FDAs concerns, the misbranding theories at issue, and key compliance considerations for telehealth, compounding, and life sciences companies.

The GLP-1 market is poised for unprecedented growth over the next 5 years, presenting a unique opportunity for digital health behavioral change